JPWO2022109313A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022109313A5 JPWO2022109313A5 JP2023530548A JP2023530548A JPWO2022109313A5 JP WO2022109313 A5 JPWO2022109313 A5 JP WO2022109313A5 JP 2023530548 A JP2023530548 A JP 2023530548A JP 2023530548 A JP2023530548 A JP 2023530548A JP WO2022109313 A5 JPWO2022109313 A5 JP WO2022109313A5
- Authority
- JP
- Japan
- Prior art keywords
- igg
- substitution
- item
- modified igg
- modified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063116491P | 2020-11-20 | 2020-11-20 | |
| US63/116,491 | 2020-11-20 | ||
| PCT/US2021/060161 WO2022109313A1 (en) | 2020-11-20 | 2021-11-19 | Bovine antibody variants |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023551194A JP2023551194A (ja) | 2023-12-07 |
| JP2023551194A5 JP2023551194A5 (https=) | 2024-11-07 |
| JPWO2022109313A5 true JPWO2022109313A5 (https=) | 2024-11-07 |
Family
ID=79018979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023530548A Pending JP2023551194A (ja) | 2020-11-20 | 2021-11-19 | ウシ科動物抗体バリアント |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230416410A1 (https=) |
| EP (1) | EP4247851A1 (https=) |
| JP (1) | JP2023551194A (https=) |
| KR (1) | KR20230110297A (https=) |
| CN (1) | CN116615463A (https=) |
| AR (1) | AR124130A1 (https=) |
| AU (1) | AU2021382704A1 (https=) |
| BR (1) | BR112023008490A2 (https=) |
| CA (1) | CA3202089A1 (https=) |
| CO (1) | CO2023007146A2 (https=) |
| MX (1) | MX2023005896A (https=) |
| WO (1) | WO2022109313A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023552456A (ja) | 2020-12-07 | 2023-12-15 | インベテックス インコーポレイテッド | 治療薬の家畜動物における半減期を増加させるための組成物及びその使用方法 |
| CN119730881A (zh) * | 2022-08-05 | 2025-03-28 | 硕腾服务有限责任公司 | 牛抗体突变体 |
| CN119968390A (zh) * | 2022-09-02 | 2025-05-09 | 硕腾服务有限责任公司 | 猪抗体突变体 |
| CN119735654B (zh) * | 2025-02-27 | 2025-07-01 | 浙江海隆生物科技股份有限公司 | 一种牛副流感病毒的亚单位hn蛋白制备方法和应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6284471B1 (en) | 1991-03-18 | 2001-09-04 | New York University Medical Center | Anti-TNFa antibodies and assays employing anti-TNFa antibodies |
| US5698762A (en) | 1994-12-09 | 1997-12-16 | Dauerman; Leonard | Microwave-assisted pyrolysis of waste polyaromatic hydrocarbons |
| US20030031671A1 (en) | 2001-08-01 | 2003-02-13 | Sydney Welt | Methods of treating colon cancer utilizing tumor-specific antibodies |
| KR20070057839A (ko) | 2004-08-19 | 2007-06-07 | 제넨테크, 인크. | 변경된 이펙터 기능을 갖는 폴리펩티드 변이체 |
| US8546543B2 (en) | 2004-11-12 | 2013-10-01 | Xencor, Inc. | Fc variants that extend antibody half-life |
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| DK1817340T3 (da) | 2004-11-12 | 2012-08-13 | Xencor Inc | Fc-varianter med ændret binding til fcrn |
| TWI633117B (zh) * | 2012-09-13 | 2018-08-21 | 必治妥美雅史谷比公司 | 結合至肌肉生長抑制素（ｍｙｏｓｔａｔｉｎ）以纖維連接蛋白爲主之支架結構域蛋白質 |
| EP3359190A4 (en) * | 2015-10-05 | 2020-05-06 | Circle33 LLC | ANTIBODIES WITH IMPROVED STABILITY ABOUT DIGESTION |
-
2021
- 2021-11-19 US US18/037,514 patent/US20230416410A1/en active Pending
- 2021-11-19 BR BR112023008490A patent/BR112023008490A2/pt unknown
- 2021-11-19 AU AU2021382704A patent/AU2021382704A1/en active Pending
- 2021-11-19 JP JP2023530548A patent/JP2023551194A/ja active Pending
- 2021-11-19 CN CN202180081802.8A patent/CN116615463A/zh active Pending
- 2021-11-19 EP EP21830362.6A patent/EP4247851A1/en active Pending
- 2021-11-19 WO PCT/US2021/060161 patent/WO2022109313A1/en not_active Ceased
- 2021-11-19 MX MX2023005896A patent/MX2023005896A/es unknown
- 2021-11-19 CA CA3202089A patent/CA3202089A1/en active Pending
- 2021-11-19 KR KR1020237020005A patent/KR20230110297A/ko active Pending
- 2021-11-23 AR ARP210103234A patent/AR124130A1/es unknown
-
2023
- 2023-05-30 CO CONC2023/0007146A patent/CO2023007146A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113840634B (zh) | 可活化蛋白质构建体及其用途 | |
| EP2409991B1 (en) | Antibody constant region variant | |
| CN104508133B (zh) | 用于产生单体和多聚体分子的方法及其用途 | |
| US11325982B2 (en) | Biparatopic and multiparatopic antibodies with common light chain and method of use | |
| JP2025134866A5 (https=) | ||
| JP7736688B2 (ja) | 多重特異性抗原結合分子を製造するための方法 | |
| JP2020103314A (ja) | コントースボディ−単鎖標的結合物質 | |
| JP2010516651A (ja) | Ｆｃ含有タンパク質の精製のための方法 | |
| CN118206639A (zh) | 与经改造的Fc构建体相关的组合物和方法 | |
| RU2016139022A (ru) | МУЛЬТИМЕРНЫЕ Fc-БЕЛКИ | |
| JP2025518971A (ja) | ｐＨ依存性ＨＳＡ結合分子及び使用方法 | |
| WO2023186120A1 (zh) | 抗血清白蛋白纳米抗体及其衍生物 | |
| CA3153085A1 (en) | Antibodies binding to cd3 and cd19 | |
| JP7752664B2 (ja) | 新規な中間体製造による持続型薬物結合体の製造方法 | |
| CN121057750A (zh) | 结合ox40l的抗体和使用方法 | |
| JP2025528213A (ja) | 複数ドメイン結合性分子 | |
| JPWO2022109313A5 (https=) | ||
| CN115151567A (zh) | 治疗性Fc组合物的化学诱导结合和解离以及T细胞接合器与人血清白蛋白的化学诱导二聚化 | |
| RU2025102187A (ru) | Мутанты бычьих антител | |
| Shukla et al. | Downstream processing of Fc fusion proteins, bispecific antibodies, and antibody–drug conjugates | |
| US20210253741A1 (en) | Bispecific antibodies | |
| CN115551538A (zh) | 干扰IL-1β受体信号转导的药剂 | |
| RU2025109063A (ru) | Мутанты антител свиных | |
| RU2025105731A (ru) | Мутанты антител свиных | |
| RU2023135094A (ru) | ВАРИАНТ Fc С ПОВЫШЕННОЙ АФФИННОСТЬЮ К Fc-РЕЦЕПТОРАМ И УЛУЧШЕННОЙ ТЕРМИЧЕСКОЙ СТАБИЛЬНОСТЬЮ |